Core Scientific Stock Up 84% as Fund Cuts Stake by $8.6 Million

Kintayl Capita sold 495,390 shares of Core Scientific in Q4, an estimated $8.64 million trade based on quarterly average prices. The disclosure represents a sizable institutional-sized reduction but is routine and provides limited insight into Core Scientific’s fundamentals, so near-term market impact is likely limited.

Analysis

Kintayl Capita sold 495,390 shares of Core Scientific in Q4, an estimated $8.64 million trade based on quarterly average prices. The disclosure represents a sizable institutional-sized reduction but is routine and provides limited insight into Core Scientific’s fundamentals, so near-term market impact is likely limited.